|
|
Volumn 9, Issue , 2013, Pages 155-163
|
|
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes
a |
|
Author keywords
hypoglycemia; incretin therapy; insulin; sulfonylurea; treatment; type 2 diabetes
|
|
Indexed keywords
ANTIDIABETIC AGENT;
BIOLOGICAL MARKER;
GLUCOSE BLOOD LEVEL;
ATTITUDE TO HEALTH;
BLOOD;
CHEMICALLY INDUCED;
DIABETES MELLITUS, TYPE 2;
DRUG EFFECTS;
ECONOMICS;
GLUCOSE BLOOD LEVEL;
HEALTH CARE COST;
HUMAN;
HYPOGLYCEMIA;
INCIDENCE;
METABOLISM;
PATIENT EDUCATION;
PATIENT SELECTION;
RISK ASSESSMENT;
RISK FACTOR;
RISK REDUCTION;
TREATMENT OUTCOME;
BIOLOGICAL MARKERS;
BLOOD GLUCOSE;
DIABETES MELLITUS, TYPE 2;
HEALTH CARE COSTS;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HUMANS;
HYPOGLYCEMIA;
HYPOGLYCEMIC AGENTS;
INCIDENCE;
PATIENT EDUCATION AS TOPIC;
PATIENT SELECTION;
RISK ASSESSMENT;
RISK FACTORS;
RISK REDUCTION BEHAVIOR;
TREATMENT OUTCOME;
|
|
EID: 84882932426
PISSN: None
EISSN: 11782048
Source Type: Journal
DOI: 10.2147/VHRM.S33934 Document Type: Review |
|
Times cited : (134)
|
|
References (0)
|